Institutional Ownership
Biomarin Pharmaceutical Inc
CUSIP 09061G101COMBMRNQ1 2026
13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
12.2%
Max % of class reported
Institutional Holders
542
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
39 filings · latest Jan 21, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 9.1% | 17.56M | SEC |
| 2 | Nov 14, 2025 | Viking Global Investors LP | 13G/A | 4.3% | 8.32M | SEC |
| 3 | Aug 14, 2025 | Primecap Management Co/Ca/ | 13G/A | 8.2% | 15.80M | SEC |
| 4 | Aug 14, 2025 | Viking Global Investors LP | 13G/A | 6.4% | 12.29M | SEC |
| 5 | May 13, 2025 | Capital Research Global Investors | 13G/A | 4.8% | 9.15M | SEC |
| 6 | Apr 29, 2025 | Blackrock, Inc. | 13G/A | 10.8% | 20.62M | SEC |
| 7 | Feb 13, 2025 | Capital Research Global Investors | 13G/A | 6.8% | 12.99M | SEC |
| 8 | Sep 30, 2024 | Viking Global Investors LP | 13G | 5.1% | 9.75M | SEC |
| 9 | Jul 10, 2024 | Vanguard Group Inc | 13G/A | 10.0% | 18.99M | SEC |
| 10 | Jul 8, 2024 | Blackrock Inc. | 13G/A | 12.0% | 22.78M | SEC |
29 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Biomarin Pharmaceutical Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 19.82M | $1.12B |
| 2 | Dodge & Cox | 14.56M | $822.59M |
| 3 | Primecap Management Co/Ca/ | 14.19M | $801.82M |
| 4 | Aqr Capital Management LLC | 7.68M | $429.35M |
| 5 | State Street Corp | 7.30M | $412.10M |
| 6 | Viking Global Investors LP | 7.06M | $398.94M |
| 7 | Citadel Advisors LLC | 4.51M | $254.92M |
| 8 | Geode Capital Management, LLC | 3.82M | $215.81M |
| 9 | Dimensional Fund Advisors LP | 3.80M | $214.80M |
| 10 | Vestal Point Capital, LP | 3.58M | $201.95M |